CHD and MONI2 selected for Innosuisse’s Core Coaching Program

CHD and MONI2 have been selected by Innosuisse to benefit from its intensive, ongoing coaching program for the development and launch of their remote, real-life pregnancy monitoring device, for both high-risk and standard pregnancies.

Among other goals, the program aims to define a detailed regulatory and certification strategy and to implement it, with a view to the commercial launch of a health-certified MONI2 in both North America and Europe from 2028.

We thank Innosuisse for their trust and look forward to this collaboration.